[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CH415963A - Masse zur Herstellung von Tabletten mit protrahierter Wirkung - Google Patents

Masse zur Herstellung von Tabletten mit protrahierter Wirkung

Info

Publication number
CH415963A
CH415963A CH1156164A CH1156164A CH415963A CH 415963 A CH415963 A CH 415963A CH 1156164 A CH1156164 A CH 1156164A CH 1156164 A CH1156164 A CH 1156164A CH 415963 A CH415963 A CH 415963A
Authority
CH
Switzerland
Prior art keywords
tablets
compound
production
protracted action
protracted
Prior art date
Application number
CH1156164A
Other languages
English (en)
Inventor
Aldo Dr Riva
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Priority to CH1156164A priority Critical patent/CH415963A/de
Priority to US482820A priority patent/US3459850A/en
Priority to GB37370/65A priority patent/GB1112332A/en
Priority to AT802665A priority patent/AT264715B/de
Priority to BR172781/65A priority patent/BR6572781D0/pt
Priority to DE19651492253 priority patent/DE1492253A1/de
Priority to FR40558A priority patent/FR4892M/fr
Publication of CH415963A publication Critical patent/CH415963A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH1156164A 1964-09-04 1964-09-04 Masse zur Herstellung von Tabletten mit protrahierter Wirkung CH415963A (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CH1156164A CH415963A (de) 1964-09-04 1964-09-04 Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US482820A US3459850A (en) 1964-09-04 1965-08-26 Sustained-release tablets,a process and a composition for their preparation
GB37370/65A GB1112332A (en) 1964-09-04 1965-09-01 Improvements in or relating to tablets
AT802665A AT264715B (de) 1964-09-04 1965-09-01 Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
BR172781/65A BR6572781D0 (pt) 1964-09-04 1965-09-01 Processo de preparacao e aplicacao de uma massa capaz de prover a liberacao pro-renda de uma substancia fisiologicamente ativa em comprimidos para administracao oral
DE19651492253 DE1492253A1 (de) 1964-09-04 1965-09-04 Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
FR40558A FR4892M (de) 1964-09-04 1965-12-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1156164A CH415963A (de) 1964-09-04 1964-09-04 Masse zur Herstellung von Tabletten mit protrahierter Wirkung

Publications (1)

Publication Number Publication Date
CH415963A true CH415963A (de) 1966-06-30

Family

ID=4374676

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1156164A CH415963A (de) 1964-09-04 1964-09-04 Masse zur Herstellung von Tabletten mit protrahierter Wirkung

Country Status (7)

Country Link
US (1) US3459850A (de)
AT (1) AT264715B (de)
BR (1) BR6572781D0 (de)
CH (1) CH415963A (de)
DE (1) DE1492253A1 (de)
FR (1) FR4892M (de)
GB (1) GB1112332A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
EP0335970B1 (de) * 1987-10-05 1992-09-02 Pharmagyn, Inc. Tablette zur behandlung bei progesteronmangel
DE19600324A1 (de) * 1996-01-08 1997-07-10 Basf Ag Granulate für kosmetische und pharmazeutische Zubereitungen
WO2002045695A2 (en) 2000-12-05 2002-06-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
ES2394455T3 (es) 2004-11-02 2013-01-31 Chr. Hansen A/S Formulaciones de bacteriófagos estabilizados
KR20200110648A (ko) 2017-12-05 2020-09-24 선오비온 파마슈티컬스 인코포레이티드 비라세믹 혼합물 및 이의 용도
AU2018378348B2 (en) 2017-12-05 2024-09-19 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
NL128902C (de) * 1960-06-06
US3346449A (en) * 1963-09-27 1967-10-10 Hoffmann La Roche d-methorphan compositions and methods of making same

Also Published As

Publication number Publication date
DE1492253A1 (de) 1969-12-18
BR6572781D0 (pt) 1973-08-02
US3459850A (en) 1969-08-05
AT264715B (de) 1968-09-10
FR4892M (de) 1967-03-06
GB1112332A (en) 1968-05-01

Similar Documents

Publication Publication Date Title
CH415963A (de) Masse zur Herstellung von Tabletten mit protrahierter Wirkung
AT273041B (de) Verfahren zur Herstellung von festen Lösungen
CH442945A (de) Verfahren zur Herstellung von Trockenapfelscheiben
AT273892B (de) Verfahren zur Herstellung von Zeolithen
AT252094B (de) Verfahren zur Herstellung von Isolierstoffen mit niedrigem spezifischem Gewicht
AT251884B (de) Verfahren zur Herstellung von transparenten Polykondensaten
AT262609B (de) Verfahren zur Herstellung von thermoplastisch-elastischen Formmassen
CH454163A (de) Verfahren zur Herstellung von Polyhalogenphenolen
CH475351A (de) Verfahren zur Herstellung von reinem Moenomycin
CH457432A (de) Verfahren zur Herstellung von 2-Hydroxyäthyl-6,8-didesoxy-6-(1-methyl-4-propyl-pyrrolidin-carboxamido)-7-O-methyl-1-thio-D-erythro-D-galacto-octopyranosid
CH468355A (de) Verfahren zur Herstellung von Isonitrilen
CH460761A (de) Verfahren zur Herstellung der 17a-ständigen Estern von 17a-Hydroxy-3-keto- 4-pregnenen
AT254423B (de) Anlage zur Herstellung von Flachglas
AT290837B (de) Herstellung thermoplastisch-elastischer Formmassen
AT256798B (de) Verfahren zur Herstellung von 2,2,3-Trichlorbutan
CH466265A (de) Verfahren zur Herstellung von Thioformamid
CH499591A (de) Herstellung von Bis-azoverbindungen
AT256808B (de) Verfahren zur Herstellung von ɛ-Caprolactam
CH457858A (de) Verfahren zur Herstellung von Trioxan-Mischpolymerisaten
CH479567A (de) Verfahren zur Herstellung von Androst- bzw. Östr-4-en-17B-yloxy-trialkylsilanen
AT260539B (de) Verfahren zur Herstellung von Schwefel-Harz-Massen
CH495931A (de) V7rfahren zur Herstellung substituierter 8-, 10- und 12-Ringe durch katalytische Co-Oligomerisation von ungesättigten Verbindungen
CH465604A (de) Verfahren zur Herstellung von Organoantimonverbindungen
CH458392A (de) Verfahren zur Herstellung von Merkaptalen
CH454162A (de) Herstellung von L-Acyloinen